Yungjin Pharm. Co., Ltd. (KRX:003520)

South Korea · Delayed Price · Currency is KRW

2,315.00

-45.00 (-1.91%)

Last updated: Jun 25, 2025

Yungjin Pharm. Market Cap

Yungjin Pharm. has a market cap or net worth of 404.19 billion as of June 27, 2025. Its market cap has increased by 8.07% in one year.

Market Cap

404.19B

Enterprise Value

n/a

Revenue

158.79B

Ranking

n/a

PE Ratio

41.32

Stock Price

2,315.00

Market Cap Chart

Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 404.19B, an increase of 554.00%. That is a compound annual growth rate of 6.00%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	404.19B	11.17%
Dec 30, 2024	363.59B	-6.45%
Dec 28, 2023	388.65B	-34.62%
Dec 29, 2022	594.40B	-38.56%
Dec 30, 2021	967.50B	-34.20%
Dec 30, 2020	1,470.46B	21.27%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.46T
Celltrion	35.49T
ALTEOGEN	20.84T
Yuhan	7,589.05B
SK Biopharmaceuticals	7,236.14B
HLB Co., Ltd.	6,512.41B
PharmaResearch	4,992.23B
Peptron	4,741.01B

Market Cap Rankings